The phosphorylation of L-plastin relies on T-cell costimulation 8, 9, which https://www.selleckchem.com/products/gdc-0068.html means it is dependent on signals from the TCR/CD3 receptor complex as well as from signals that origin from accessory receptor. The inhibition of L-plastin phosphorylation by dexamethasone could be

reverted by the synthetic steroid mifepristone, which shows a glucocorticoid receptor dependency 36. Thus, effects of dexamethasone on L-plastin phosphorylation are most likely due to gene expression, suggesting an interference with the signaling pathway upstream of L-plastin phosphorylation. It is known that dexamethasone inhibits proximal signals induced by TCR triggering 37–40. In addition, dexamethasone could interfere with CD28-mediated signals. PI3K activity was shown to be involved in CD28-mediated costimulation 41–43 Selleck PI3K inhibitor and its inhibition interferes with L-plastin phosphorylation in immune complex-stimulated

PMN 44. Dexamethasone inhibits PI3K in mast cells 45, which suggests PI3K and its inhibition might be involved in L-plastin phosphorylation upon T-cell costimulation. However, the relevance of dexamethasone for CD28-mediated PI3K activation in primary human T cells remains to be determined. One function of costimulation is the receptor movement to the immunological synapse 7, 12. Consequently, interference with L-plastin expression 5 or phosphorylation (this study) disturbed LFA-1 accumulation in the immune synapse. Interestingly, the effects on the accumulation of CD3 were much weaker and not significant in 5A-LPL-expressing T cells. It was therefore tempting to speculate that L-plastin phosphorylation Oxymatrine plays a role in peripheral SMAC, but not in central SMAC formation. The fact that 5E-LPL expression rescued only the LFA-1, but not the CD3 enrichment in dexamethasone-treated T cells strengthened that assumption. Interestingly, migration

of the TCR/CD3 complex toward the central SMAC depends on the actin cytoskeleton, as shown by the application of mycotoxins (e.g. cytochalasin D) 2. However, although 5A-LPL expression led to a lower F-actin content in stimulated T cells, the CD3 accumulation was not significantly disturbed. This might be due to the mode of inhibition of the actin cytoskeleton. Thus, in contrast to 5A-LPL expression, the application of mycotoxins to inhibit the actin cytoskeleton does not take into account the complex and spatio-temporal regulation of the actin cytoskeleton. In contrast to 5A-LPL expression, dexamethasone inhibits both the enrichment of the central SMAC-marker CD3 and the peripheral SMAC-marker LFA-1 in the immune synapse significantly. The difference between 5A-LPL expression and dexamethasone treatment on the CD3 enrichment in the immune synapse could be due to additional effects of dexamethasone on the actin cytoskeleton or signaling cascades.

No related posts.